Phytochemistry, Bioactivities, Pharmacokinetics and Toxicity Prediction of Selaginella repanda with Its Anticancer Potential against Human Lung, Breast and Colorectal Carcinoma Cell Lines
Open Access
- 2 February 2021
- Vol. 26 (3), 768
- https://doi.org/10.3390/molecules26030768
Abstract
In this study, we investigated the bioactive potential (antibacterial and antioxidant), anticancer activity and detailed phytochemical analysis of Selaginellarepanda (S. repanda) ethanolic crude extract for the very first time using different in vitro approaches. Furthermore, computer-aided prediction of pharmacokinetic properties and safety profile of the identified phytoconstituents were also employed in order to provide some useful insights for drug discovery. S. repanda, which is a rich source of potent natural bioactive compounds, showed promising antibacterial activity against the tested pathogenic bacteria (S. aureus, P. aeruginosa, E. coli and S. flexneri). The crude extract displayed favorable antioxidant activity against both 2,2-diphenyl-1-picrylhydrazyl (DPPH) (IC50 = 231.6 μg/mL) and H2O2 (IC50 = 288.3 μg/mL) molecules. S. repanda also showed favorable and effective anticancer activity against all three malignant cancer cells in a dose/time dependent manner. Higher activity was found against lung (A549) (IC50 = 341.1 μg/mL), followed by colon (HCT-116) (IC50 = 378.8 μg/mL) and breast (MCF-7) (IC50 = 428.3 μg/mL) cancer cells. High resolution-liquid chromatography–mass spectrometry (HR-LC–MS) data of S. repanda crude extract revealed the presence of diverse bioactive/chemical components, including fatty acids, alcohol, sugar, flavonoids, alkaloids, terpenoids, coumarins and phenolics, which can be the basis and major cause for its bioactive potential. Therefore, achieved results from this study confirmed the efficacy of S. repanda and a prospective source of naturally active biomolecules with antibacterial, antioxidant and anticancer potential. These phytocompounds alone with their favorable pharmacokinetics profile suggests good lead and efficiency of S. repanda with no toxicity risks. Finally, further in vivo experimental investigations can be promoted as probable candidates for various therapeutic functions, drug discovery and development.Funding Information
- Scientific Research Deanship at University of Ha’il-Saudi Arabia (RG-191194)
This publication has 70 references indexed in Scilit:
- Glutamic acid as anticancer agent: An overviewSaudi Pharmaceutical Journal, 2013
- Halomonas sp. BS4, A biosurfactant producing halophilic bacterium isolated from solar salt works in India and their biomedical importanceSpringerPlus, 2013
- Antinociceptive effect of ethanolic extract of Selaginella convoluta in miceBMC Complementary and Alternative Medicine, 2012
- Antitumor Effects of cis-Urocanic Acid on Experimental Urothelial Cell Carcinoma of the BladderJournal of Urology, 2012
- Synthesis and in vitro antimicrobial evaluation of novel fluoroquinolone derivativesEuropean Journal of Medicinal Chemistry, 2010
- Preliminary phytochemical and antimicrobial studies on a spike-moss Selaginella inaequalifolia (hook. & grev.) SpringAsian Pacific Journal of Tropical Medicine, 2010
- Free radicals, antioxidants and functional foods: Impact on human healthPharmacognosy Reviews, 2010
- Analysis of phenolic compounds and radical scavenging activity of Echinacea spp.Journal of Pharmaceutical and Biomedical Analysis, 2004
- Pulegone-Rich Essential Oils of TurkeyJournal of Essential Oil Research, 1998
- Differential inhibitory effects of various herb extracts on the activities of reverse transcriptase and various deoxyribonucleic acid(DNA) polymerases.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989